Evidence map›Paper›PMID 40826378›Full record

ArticleJournal of health, population, and nutrition2025

Prevalence and risk factors of self-medication with antibiotics in the general population of Tehran-a population-based study.

Keyvan Karimi, Yosra Azizpour, Maryam Shafaati, Erta Rajabi, Maryam Zare, Arash Seifi, Ozra Tabatabaei-Malazy, Samaneh Akbarpour, Mahnaz Khalafehnilsaz

Abstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Keyvan Karimi *Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Yosra Azizpour *Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maryam ShafaatiResearch Center for Antibiotic Stewardship and Antimicrobial Resistance, Infectious Diseases Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. Maryam.shafaati@gmail.com.
Erta RajabiResearch Center for Antibiotic Stewardship and Antimicrobial Resistance, Infectious Diseases Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Maryam ZareVirology Department of Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Arash SeifiResearch Center for Antibiotic Stewardship and Antimicrobial Resistance, Infectious Diseases Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Ozra Tabatabaei-MalazyNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Samaneh AkbarpourNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. akbarpour691@gmail.com.
Mahnaz KhalafehnilsazSchool of Health and Society, Faculty of Education Health and Wellbeing, University of Wolverhampton, Wolverhampton, WV1 1LY, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiven the ongoing global threat of antimicrobial resistance (AMR), largely fueled by self-medication with antibiotics (SMA), this study offers important insights from southern Tehran-an underrepresented region in national data-regarding the prevalence and determinants of SMA. We investigated several previously underexplored key factors, including socioeconomic status (SES), education, lifestyle, mental health, and COVID-19 history.

methodsA population-based cross-sectional telephone survey was conducted in three major regions of southern Tehran in 2023, involving 1,311 adult participants who were selected through stratified random sampling with probability proportional to size. A structured composite index was developed using data on lifestyle factors such as body mass index, physical activity, smoking, nutrition, mental and physical health, socioeconomic status, and frequency of SMA.

resultsOf the participants, 50.4% were male and 49.6% female, with an overall SMA prevalence of 21.3% (n = 279). Higher education (AOR = 1.93, 95% CI = 1.25-2.96, p value = 0.003), higher SES (AOR = 3.59, 95% CI = 1.82-6.82, p value < 0.001), basic insurance (AOR = 1.69, 95% CI = 1.10-2.63, p value = 0.019), and a history of uncomplicated COVID-19 infection (AOR = 2.30, 95% CI = 1.44-3.78, p value = 0.001) were significantly associated with increased SMA. In contrast, a healthy lifestyle (AOR = 0.66, p value = 0.033) and good mental health (AOR = 0.31, p value < 0.001) were associated with lower SMA rates.

conclusionOur findings primarily suggest that we should focus our public health efforts on specific subpopulations affected by SMA. Community-based antibiotic stewardship programs should use educational and behavioral approaches with an emphasis on mental health and health literacy. Policymakers should also consider whether to modify regulations to prevent the general public from obtaining antibiotics without a prescription. Finally, the findings from a representative sample from southern Tehran illustrate the value of local data in national AMR decision-making and avoiding assumptions.

Indexed as

Anti-Bacterial AgentsSelf MedicationAdolescentAdultAgedCOVID-19Cross-Sectional StudiesEducational StatusFemaleHumansIranLife StyleMaleMental HealthMiddle AgedPrevalenceAnti-Bacterial AgentsAntibioticsAntimicrobial resistanceIranPublic healthRisk factorsSelf-medication

Identifiers

PMID40826378
PMCPMC12363102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.